Table of Content

1 Engineered T Cells Market Introduction and Overview
1.1 Engineered T Cells Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Engineered T Cells Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Engineered T Cells Revenue and Market Share by Type
3 Global Engineered T Cells Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Engineered T Cells Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Engineered T Cells Market Size (2019-2024)
4.2 Engineered T Cells Growth Trends Analysis by Regions
4.2.1 Engineered T Cells Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Engineered T Cells Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Engineered T Cells Market Size (2019-2024)
4.2.4 Europe Engineered T Cells Market Size (2019-2024)
4.2.5 Asia-Pacific Engineered T Cells Market Size (2019-2024)
4.2.6 Latin America Engineered T Cells Market Size (2019-2024)
4.2.7 Middle East & Africa Engineered T Cells Market Size (2019-2024)
5 North America
5.1 North America Engineered T Cells Revenue by Countries
5.1.1 North America Engineered T Cells Revenue by Countries (2019-2024)
5.2 North America Engineered T Cells Revenue by Types
5.3 North America Engineered T Cells Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Engineered T Cells Revenue by Countries
6.1.1 Asia Pacific Engineered T Cells Revenue by Countries (2019-2024)
6.2 Asia Pacific Engineered T Cells Revenue by Types
6.3 Asia Pacific Engineered T Cells Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Engineered T Cells Revenue by Countries
7.1.1 Europe Engineered T Cells Revenue by Countries (2019-2024)
7.2 Europe Engineered T Cells Revenue by Types
7.3 Europe Engineered T Cells Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Engineered T Cells Revenue by Countries
8.1.1 Latin America Engineered T Cells Revenue by Countries (2019-2024)
8.2 Latin America Engineered T Cells Revenue by Types
8.3 Latin America Engineered T Cells Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Engineered T Cells Revenue by Countries
9.1.1 Middle East & Africa Engineered T Cells Revenue by Countries (2019-2024)
9.2 Middle East & Africa Engineered T Cells Revenue by Types
9.3 Middle East & Africa Engineered T Cells Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Engineered T Cells Market Competition, by Players
10.1 Global Engineered T Cells Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Engineered T Cells Players Market Share in 2023
10.2.2 Top 6 Engineered T Cells Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Engineered T Cells Players Head Office, Business Provided
10.4 Engineered T Cells Mergers & Acquisitions
10.5 Engineered T Cells New Entrants and Expansion Plans
11 Players Profiles11.1 Autolus Limited
11.1.1 Autolus Limited Company Profile
11.1.2 Engineered T Cells Product Overview
11.1.3 Autolus Limited Engineered T Cells Market Performance (2019-2024)
11.1.4 Autolus Limited Business Overview
11.1.5 Recent Developments and Plans
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Profile
11.2.2 Engineered T Cells Product Overview
11.2.3 Bellicum Pharmaceuticals Engineered T Cells Market Performance (2019-2024)
11.2.4 Bellicum Pharmaceuticals Business Overview
11.2.5 Recent Developments and Plans
11.3 Cells Medica
11.3.1 Cells Medica Company Profile
11.3.2 Engineered T Cells Product Overview
11.3.3 Cells Medica Engineered T Cells Market Performance (2019-2024)
11.3.4 Cells Medica Business Overview
11.3.5 Recent Developments and Plans
11.4 Elli Lilly and Company
11.4.1 Elli Lilly and Company Company Profile
11.4.2 Engineered T Cells Product Overview
11.4.3 Elli Lilly and Company Engineered T Cells Market Performance (2019-2024)
11.4.4 Elli Lilly and Company Business Overview
11.4.5 Recent Developments and Plans
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Profile
11.5.2 Engineered T Cells Product Overview
11.5.3 Gilead Sciences Engineered T Cells Market Performance (2019-2024)
11.5.4 Gilead Sciences Business Overview
11.5.5 Recent Developments and Plans
11.6 Juno Therapeutics
11.6.1 Juno Therapeutics Company Profile
11.6.2 Engineered T Cells Product Overview
11.6.3 Juno Therapeutics Engineered T Cells Market Performance (2019-2024)
11.6.4 Juno Therapeutics Business Overview
11.6.5 Recent Developments and Plans
11.7 Novartis
11.7.1 Novartis Company Profile
11.7.2 Engineered T Cells Product Overview
11.7.3 Novartis Engineered T Cells Market Performance (2019-2024)
11.7.4 Novartis Business Overview
11.7.5 Recent Developments and Plans
11.8 Oxford Biomedica
11.8.1 Oxford Biomedica Company Profile
11.8.2 Engineered T Cells Product Overview
11.8.3 Oxford Biomedica Engineered T Cells Market Performance (2019-2024)
11.8.4 Oxford Biomedica Business Overview
11.8.5 Recent Developments and Plans
11.9 Pfizer
11.9.1 Pfizer Company Profile
11.9.2 Engineered T Cells Product Overview
11.9.3 Pfizer Engineered T Cells Market Performance (2019-2024)
11.9.4 Pfizer Business Overview
11.9.5 Recent Developments and Plans
11.10 Precision Bioscience
11.10.1 Precision Bioscience Company Profile
11.10.2 Engineered T Cells Product Overview
11.10.3 Precision Bioscience Engineered T Cells Market Performance (2019-2024)
11.10.4 Precision Bioscience Business Overview
11.10.5 Recent Developments and Plans
11.11 Redmile Group
11.11.1 Redmile Group Company Profile
11.11.2 Engineered T Cells Product Overview
11.11.3 Redmile Group Engineered T Cells Market Performance (2019-2024)
11.11.4 Redmile Group Business Overview
11.11.5 Recent Developments and Plans
11.12 Seeking Alpha
11.12.1 Seeking Alpha Company Profile
11.12.2 Engineered T Cells Product Overview
11.12.3 Seeking Alpha Engineered T Cells Market Performance (2019-2024)
11.12.4 Seeking Alpha Business Overview
11.12.5 Recent Developments and Plans
11.13 Unum Therapeutics
11.13.1 Unum Therapeutics Company Profile
11.13.2 Engineered T Cells Product Overview
11.13.3 Unum Therapeutics Engineered T Cells Market Performance (2019-2024)
11.13.4 Unum Therapeutics Business Overview
11.13.5 Recent Developments and Plans
12 Global Engineered T Cells Forecast Market Analysis by Type
12.1 Global Engineered T Cells Revenue Market Forecast by Type (2024-2030)
13 Global Engineered T Cells Forecast Market Analysis by Application
13.1 Engineered T Cells Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Engineered T Cells Forecast Market Size (2024-2030)
14.2 Engineered T Cells Growth Trends Forecast Analysis by Regions
14.2.1 Engineered T Cells Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Engineered T Cells Forecast Market Size (2024-2030)
14.2.3 Europe Engineered T Cells Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Engineered T Cells Forecast Market Size (2024-2030)
14.2.5 Latin America Engineered T Cells Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Engineered T Cells Forecast Market Size (2024-2030)
15 Engineered T Cells Industry Dynamic Analysis
15.1 Engineered T Cells Market Trends Analysis
15.2 Engineered T Cells Market Drivers Analysis
15.3 Engineered T Cells Market Challenges Analysis
15.4 Engineered T Cells Market Restraints Analysis